De novo hepatocellular carcinoma in a liver graft with sustained hepatitis C virus clearance after living donor liver transplantation

Liver Transplantation

Volumn 15, Issue 11, 2009, Pages 1412-1416

  Morita, Kazutoyo ^a   Taketomi, Akinobu ^a   Soejima, Yuji ^a   Ikegami, Toru ^a   Fukuhara, Takasuke ^a   Iguchi, Tomohiro ^a   Nagata, Shigeyuki ^a   Sugimachi, Keishi ^a   Gion, Tomonobu ^a   Shirabe, Ken ^a   Maehara, Yoshihiko ^a  

^a KYUSHU UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BASILIXIMAB; INTERFERON; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PEGINTERFERON ALPHA2B; RIBAVIRIN; TACROLIMUS;

ADULT; ARTICLE; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; FEMALE; FOLLOW UP; HEPATITIS C; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOSUPPRESSIVE TREATMENT; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER FAILURE; LIVER FIBROSIS; LIVER FUNCTION TEST; LIVER GRAFT; LIVER RESECTION; LIVER TRANSPLANTATION; LIVING DONOR; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RECIPIENT; RECURRENT INFECTION;

ADULT; CARCINOMA, HEPATOCELLULAR; DNA, NEOPLASM; FEMALE; HEPATITIS C, CHRONIC; HUMANS; LIVER CIRRHOSIS; LIVER NEOPLASMS; LIVER TRANSPLANTATION; LIVING DONORS; MICROSATELLITE REPEATS; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS;

EID: 72949108415     PISSN: 15276465     EISSN: 15276473     Source Type: Journal    
DOI: 10.1002/lt.21894     Document Type: Article

References (20)

1. Mazzaferro V, Regalia E, Doci R, Andreola R, Pulvirenti A, Bozzetti F, et al. Liver transplantation for the treatment of small hepatocellular carcinoma. N Engl J Med 1996;334:693-699.
2. Todo S, Furukawa H, for the Japan Study Group on Organ Transplantation. Living donor liver transplantation for adult patients with hepatocellular carcinoma: experience in Japan. Ann Surg 2004;240:451-461.
3. Taketomi A, Sanefuji K, Soejima Y, Yoshizumi T, Uchiyama H, Ikegami T, et al. Impact of des-gamma-carboxy prothrombin and tumor size on the recurrence of hepatocellular carcinoma after living donor liver transplantation. Transplantation 2009;87:531-537.
4. Saxena R, Ye MQ, Emre S, Klion F, Nalesnik MA, Thung SN. De novo hepatocellular carcinoma in a hepatic allograft with recurrent hepatitis C cirrhosis. Liver Transpl Surg 1999;5:81-82. (Pubitemid 29037358)
5. Levitsky J, Faust TW, Cohen SM, Te HS. Group G streptococcal bacteremia and de novo hepatocellular carcinoma after liver transplantation. Liver Transpl 2002;8:572. (Pubitemid 34619093)
6. Croitoru A, Schiano TD, Schwartz M, Roayaie S, Xu R, Suriawinata A, et al. De novo hepatocellular carcinoma occurring in a transplanted liver: case report and review of the literature. Dig Dis Sci 2006;51:1780-1782.
7. Sotiropoulos GC, Frilling A, Molmenti EP, Brokalaki EI, Beckebaum S, Omar OS, et al. De novo hepatocellular carcinoma in recurrent liver cirrhosis after liver transplantation for benign hepatic disease: is a deceased donor retransplantation justified? Transplantation 2006;82:1112.
8. Flemming P, Tillmann HL, Barg-Hock H, Kleeberger W, Manns MP, Klempnauer J, et al. Donor origin of de novo hepatocellular carcinoma in hepatic allografts. Transplantation 2003;76:871-873. (Pubitemid 37140236)
9. Torbenson M, Grover D, Boitnott J, Klein A, Molmenti E. De novo hepatocellular carcinoma in a liver allograft associated with recurrent hepatitis B. Transplant Proc 2005;37:2205-2206. (Pubitemid 40956412)
10. Kita Y, Klintmalm G, Kobayashi S, Yanaga K. Retransplantation for de novo hepatocellular carcinoma in the liver allograft with recurrent hepatitis B cirrhosis 14 years after primary liver transplantation. Dig Dis Sci 2007;52:3392-3393. (Pubitemid 350077162)
11. Bruno S, Stroffolini T, Colombo M, Bollani S, Benvegnù L, Mazzella G, et al. Sustained virological response to interferon-alpha is associated with improved outcome in HCVrelated cirrhosis. A retrospective study. Hepatology 2007;45:579-587.
12. Makiyama A, Itoh Y, Kasahara A, Imai Y, Kawata S, Yoshioka K, et al. Characteristics of patients with chronic hepatitis C who develop hepatocellular carcinoma after a sustained response to interferon therapy. Cancer 2004;101:1616-1622. (Pubitemid 39318909)
13. Sanefuji K, Kayashima H, Iguchi T, Sugimachi K, Yamashita Y, Yoshizumi T, et al. Characterization of hepatocellular carcinoma developed after achieving sustained virological response to interferon therapy for hepatitis C. J Surg Oncol 2009;99:32-37.
14. Hayashi Y, Tamori A, Nishikawa M, Morikawa H, Enomoto M, Sakaguchi H, et al. Differences in molecular alterations of hepatocellular carcinoma between patients with a sustained virological response and those with hepatitis C virus infection. Liver Int 2009;29:126-132.
15. Taketomi A, Kayashima H, Soejima Y, Yoshizumi T, Uchiyama H, Ikegami T, et al. Donor risk in adult-to-adult living donor liver transplantation: impact of left lobe graft. Transplantation 2009;87:445-450.
16. Soejima Y, Taketomi A, Yoshizumi T, Uchiyama H, Harada N, Ijichi H, et al. Feasibility of left lobe living donor liver transplantation between adults: an 8-year, single-center experience of 107 cases. Am J Transplant 2006;6:1004-1011. (Pubitemid 44356651)
17. Bedossa P, Poynard T, for the METAVIR Cooperative Study Group. An algorithm for the grading of activity in chronic hepatitis C. Hepatology 1996;24:289-293.
18. Hove WR, Van Hoek B, Bajema IM, Ringers J, Van Krieken JH, Lagaaij EL. Extensive chimerism in liver transplants: vascular endothelium, bile duct epithelium, and hepatocytes. Liver Transpl 2003;9:552-556. (Pubitemid 36701689)
19. Tong MJ, el Farra NS, Reikes AR, Co RL. Clinical outcomes after transfusion-associated hepatitis C. N Engl J Med 1995;332:1463-1466.
20. Oda S, Maehara Y, Ikeda Y, Oki E, Egashira A, Okamura Y, et al. Two modes of microsatellite instability in human cancer: differential connection of defective DNA mismatch repair to dinucleotide repeat instability. Nucleic Acids Res 2005;33:1628-1636. (Pubitemid 41418390)